Who invested in Cardior Pharmaceuticals

2 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcarePharma

Funding summaryUpdated 26 Oct 2026

$92Mraised across 2 rounds since 2017, from 2 sources

$16MSeries A$75MSeries B

Latest round: Series B, $75MAug 2021
Step-upi: 4.6×
Investors: 6

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2018201920202021

$16MSeries A$75MSeries B

First round: Series A, $16M
Biggest round: $75M
Between rounds: 4.3 years

The rounds

Aug 2021
Series B$75M1 new
- EQT Life Sciences
Source recorded
May 2017
Series A$16M5 new
Reported by FinSMEs

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series A2017Series B2021

HTGF High-Tech Gründerfonds

EQT Life Sciences

BioMedPartners

Bristol Myers SquibbBoehringer IngelheimLSP (Life

Everyone who backed them

HTGF High-Tech GründerfondsVC firm1round

EQT Life SciencesVC firm1round

BioMedPartnersPrivate equity1round

Bristol Myers SquibbVC firm1round

Boehringer IngelheimVC firm1round

LSP (Lifeno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Cardior Pharmaceuticals as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

InkefVC firmPer its own site

Quick answers about Cardior Pharmaceuticals

Who invested in Cardior Pharmaceuticals?

Cardior Pharmaceuticals's investors include HTGF High-Tech Gründerfonds, EQT Life Sciences, BioMedPartners, Bristol Myers Squibb and Boehringer Ingelheim, and 1 more on record.

How much has Cardior Pharmaceuticals raised?

Cardior Pharmaceuticals has raised $92M across 2 rounds since 2017.

When did Cardior Pharmaceuticals last raise?

Cardior Pharmaceuticals's most recent round was a Series B of $75M in Aug 2021.

What was Cardior Pharmaceuticals's biggest round?

Its most recent round, $75M in Aug 2021, is also its largest on record.

Who backed Cardior Pharmaceuticals first?

Cardior Pharmaceuticals's first round on record, in May 2017, was backed by HTGF High-Tech Gründerfonds, BioMedPartners and Bristol Myers Squibb and 2 others.